Trial Profile
Double-Blind, Randomized, Dose Optimization Trial of Three Doses of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) in Multiple Antiretroviral Drug-Experienced Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2023
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Tipranavir (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 16 Nov 2006 New trial record.